Karuna Therapeutics, Inc.

Welcome to the Karuna Therapeutics First Quarter 2023 Financial Results Conference Call. All participants are in a listen-only mode. Please note this call is being recorded. And I will now turn the call over to Alexis Smith, Senior Director of Investor Relations.

Thank you.

Good morning, everyone, and thank you for joining our First Quarter 2023 Financial Results Conference Call. I'm joined on the call today by Bill Meary, President and Chief Executive Officer, and Troy Agnalzi, Chief Financial Officer, who will begin our call with prepared remarks, as well as Andrew Miller, Founder and Chief Operating Officer, and Will Kane, Chief Commercial Officer, who will join Bill and Troy for the Q&A portion of our call. Before we begin, I encourage everyone to visit the Investors page of our website at investors.coronatx.com to find our press release and presentation related to today's call. Forward-looking statements related to our product development, regulatory and commercialization plans, our research activities, and financial outlook may be presented during this call. Please revert to today's press release and our SEC filings for important risk factors that could cause our actual performance and results to differ materially from those expressed or implied in these forward-looking statements. And now, I'll hand it over to Bill.